Catalyst Wire Dossier Catalyst Wire Dossier

Umbilical cord-derived Wharton's jelly stem cells

Wharton's jelly-derived mesenchymal stem cells · University of Kansas Medical Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Umbilical cord-derived Wharton's jelly stem cells, covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease [Phase 1]

See pricing